Cargando…

Optimal Management of Severe/Refractory Asthma

Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakhale, Smita, Mulpuru, Sunita, Boyd, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165919/
https://www.ncbi.nlm.nih.gov/pubmed/21912491
http://dx.doi.org/10.4137/CCRPM.S5535
_version_ 1782211098326335488
author Pakhale, Smita
Mulpuru, Sunita
Boyd, Matthew
author_facet Pakhale, Smita
Mulpuru, Sunita
Boyd, Matthew
author_sort Pakhale, Smita
collection PubMed
description Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite treatment with high doses of inhaled and ingested corticosteroids, asthmatic patients are predisposed to greater morbidity and require more health care support. Treating patients with severe asthma can be difficult and often poses a challenge to physicians when providing ongoing management. This clinical review aims to discuss the definition, prevalence and evaluation of severe asthmatics, and provides a review of the existing pharmacologic and non-pharmacologic treatment options.
format Online
Article
Text
id pubmed-3165919
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-31659192011-09-12 Optimal Management of Severe/Refractory Asthma Pakhale, Smita Mulpuru, Sunita Boyd, Matthew Clin Med Insights Circ Respir Pulm Med Review Asthma is a chronic inflammatory disease of the airways, affecting approximately 300 million people worldwide. Asthma results in airway hyperresponsiveness, leading to paroxysmal symptoms of wheeze, cough, shortness of breath, and chest tightness. When these symptoms remain uncontrolled, despite treatment with high doses of inhaled and ingested corticosteroids, asthmatic patients are predisposed to greater morbidity and require more health care support. Treating patients with severe asthma can be difficult and often poses a challenge to physicians when providing ongoing management. This clinical review aims to discuss the definition, prevalence and evaluation of severe asthmatics, and provides a review of the existing pharmacologic and non-pharmacologic treatment options. Libertas Academica 2011-08-31 /pmc/articles/PMC3165919/ /pubmed/21912491 http://dx.doi.org/10.4137/CCRPM.S5535 Text en © the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Review
Pakhale, Smita
Mulpuru, Sunita
Boyd, Matthew
Optimal Management of Severe/Refractory Asthma
title Optimal Management of Severe/Refractory Asthma
title_full Optimal Management of Severe/Refractory Asthma
title_fullStr Optimal Management of Severe/Refractory Asthma
title_full_unstemmed Optimal Management of Severe/Refractory Asthma
title_short Optimal Management of Severe/Refractory Asthma
title_sort optimal management of severe/refractory asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165919/
https://www.ncbi.nlm.nih.gov/pubmed/21912491
http://dx.doi.org/10.4137/CCRPM.S5535
work_keys_str_mv AT pakhalesmita optimalmanagementofsevererefractoryasthma
AT mulpurusunita optimalmanagementofsevererefractoryasthma
AT boydmatthew optimalmanagementofsevererefractoryasthma